From 31 May till 4 June 2024: HIGHLIGHTS FROM ASCO

Your direct line with Chicago

The American Society of Clinical Oncology (ASCO) 2024 brings together leading experts in the different fields of cancer from around the world. And, as usual, they gather together in Chicago, USA. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.

Stay tuned, and get ready for an exciting and informative journey!

With the educational support of:

In the spotlight:

The B.J. Kennedy Geriatric Oncology Award

The G-oncoCOACH study

Cindy Kenis, a Nurse Specialist in Geriatric Oncology at the University Hospital of Leuven, presented at ASCO the results of the G-oncoCOACH study during the oral abstract session of the

See video »

Highlights from the Clinical Science Symposium

ASCO 2024 Plenary session

We are excited to share exclusive insights from the ASCO 2024 Plenary session, featuring discussions and results from four pivotal studies. Our experts delve into the implications of these findings for clinical practice. Watch the videos to stay updated on the latest advancements in oncology research.

ADRIATIC trial (ASCO plenary)

Over the last decades, therapeutic advances for patients with limited-stage small-cell lung cancer (LS-SCLC) have been limited. With the current standard of care (i.e., concurrent chemoradiotherapy [cCRT]), the prognosis for these patients is poor

See video »

LAURA trial (ASCO plenary)

Based on the results of the phase III PACIFIC trial, consolidation therapy with durvalumab has become the standard of care for patients with unresectable stage III NSCLC who did not suffer disease progression under

See video »

NADINA trial (ASCO plenary)

Prof Dr Christian Blank, a medical oncologist at the Netherlands Cancer Institute, presented the first data from the NADINA trial at the ASCO 2024 plenary session.
This investigator-initiated trial compared neo-adjuvant ipilimumab plus nivolumab

See video »

ESOPEC trial (ASCO plenary)

Prof Dr Jeroen Dekervel from UZ Leuven (Belgium) and Prof Dr Florian Lordick from the University of Leipzig (Germany) discuss the ESOPEC trial.
The ESOPEC trial focused on patients with adenocarcinoma of the

See video »

Latest daily highlights

Highlights on head & neck cancer 2

Dr Marika Rasschaert, a medical oncologist at the University Hospital Antwerp, Belgium, provided a comprehensive overview of critical studies presented at ASCO 2024 in the oral abstract session on Head

See video »

Highlights on lung cancer 4

Dr Lizza Hendriks, a respiratory oncologist at the Maastricht University Medical Center (Netherlands), highlights four significant presentations on NSCLC from ASCO 2024 relevant to clinical practice.
A noteworthy presentation at

See video »

Highlights on breast cancer 2

Dr Luca Arecco, a medical oncologist at the University of Genova (Italy) and the Institut Jules Bordet (Belgium), presents four trials from the oral abstract session on the adjuvant early

See video »

Highlights on melanoma/skin cancer 3

Prof Dr Jean-François Baurain, a medical oncologist at the Cliniques Universitaires Saint-Luc, Brussels presents an update on advanced melanoma from ASCO.
An updated analysis of the RELATIVITY-047 trial, which compared

See video »

Highlights on gynaecological cancer

Prof Hannelore Denys, a medical oncologist at the University Hospital Ghent, Belgium, provided a comprehensive overview of critical studies presented at ASCO 2024 in the Gynaecological Cancers session.
The BrUOG

See video »

Highlights on lung cancer 3

Dr Charlotte De Bondt, thoracic oncologist at GZA Hospitals, Antwerp presents her selection of highlights from the rapid oral abstract session on lung cancer. Dr Jonathan Spicer presented a four-year

See video »

Highlights on head & neck cancer 1

Dr Willem Lybaert, medical oncologist at VITAZ Sint-Niklaas and University Hospital Antwerp, presents highlights from the rapid oral abstract session on head & neck cancer. The phase 1 TARGET-HPV trial

See video »

Highlights on CNS

Dr Marika Rasschaert, a medical oncologist at the University Hospital Antwerp, Belgium, provided a comprehensive overview of critical studies presented at ASCO 2024 in the Central Nervous System Tumours session.

See video »

Highlights on melanoma/skin cancer 1

Prof Dr Jean-François Baurain, a medical oncologist at the Cliniques Universitaires Saint-Luc, Brussels presents a first selection of interesting highlights in melanoma and skin cancer.
The COMBI-AD study assessed adjuvant

See video »

Highlights on GI cancer 2

Prof. Alain Hendlisz, a digestive oncologist at the Institut Jules Bordet in Brussels, Belgium, provided a comprehensive overview of key studies presented at ASCO 2024 in the rapid oral abstract

See video »

Highlights on urothelial cancer

Dr Jérémy Blanc, medical oncologist in training from the Institut Jules Bordet, Brussels selected highlights on bladder cancer from ASCO24. Dr Jae-Lyun Lee presented the first results from the

See video »

Highlights on GI cancer 1

Prof Eric Van Cutsem, a digestive oncologist at University Hospitals, Belgium, provided a comprehensive overview of key studies presented at ASCO 2024 in the session on colorectal and anal cancer.

See video »

Highlights on lung cancer 2

Dr Dieter Stevens, a thoracic oncologist at University Hospitals Gent in Belgium, shares key findings from ASCO2024 on advanced or metastatic NSCLC patients with rare oncogenic alterations.

See video »

Highlights on breast cancer 1

Dr Elisa Agostinetto, a medical oncologist and research fellow at Institut Jules Bordet in Brussels, Belgium, provides a comprehensive overview of five selected abstracts presented at ASCO 2024 during the

See video »

Highlights on prostate cancer 1

Prof Piet Dirix, radiation oncologist at the Iridium Network in Antwerp highlights the most interesting presentations from the oral abstract session on prostate cancer (PCa). Extensive preclinical data suggest that

See video »

Highlights on lung cancer 1

Prof Dr Christophe Dooms, a respiratory oncologist at the University Hospitals Leuven (Belgium), highlights three significant presentations on mNSCLC from ASCO 2024 relevant to clinical practice. The first trial, NRG-LU002,

See video »

Z1. Researchpark 30, 1731 Zellik, Belgium
Website created by MediMix © 2023 - Privacy Policy